메뉴 건너뛰기




Volumn 331, Issue 1, 2007, Pages 84-92

In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles

Author keywords

Carbamazepine; Coacervation; Dissolution rate; Enteric polymer; Microencapsulation

Indexed keywords

CARBAMAZEPINE; ETHYL CELLULOSE; EUDRAGIT; METHYLCELLULOSE; NANOPARTICLE; POLYMER; STABILIZING AGENT; WATER;

EID: 33846562075     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.018     Document Type: Article
Times cited : (47)

References (23)
  • 1
    • 0017946933 scopus 로고
    • Clinical pharmacokinetics of carbamazepine
    • Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin. Pharmacokinet. 3 (1978) 128-143
    • (1978) Clin. Pharmacokinet. , vol.3 , pp. 128-143
    • Bertilsson, L.1
  • 2
    • 0343953614 scopus 로고    scopus 로고
    • Oral bioavailability of a poorly water-soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state
    • De Jaeghere F., Allemann E., Kubel F., Galli B., Cozen R., Doelker E., and Gurny R. Oral bioavailability of a poorly water-soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J. Control. Release 68 (2000) 291-298
    • (2000) J. Control. Release , vol.68 , pp. 291-298
    • De Jaeghere, F.1    Allemann, E.2    Kubel, F.3    Galli, B.4    Cozen, R.5    Doelker, E.6    Gurny, R.7
  • 3
    • 0035783268 scopus 로고    scopus 로고
    • pH-dependent dissolving nano- and micro-particles for improved peroral delivery of a highly lipophilic compound in dogs
    • De Jaeghere F., Allemann E., Doelker E., and Gurry R. pH-dependent dissolving nano- and micro-particles for improved peroral delivery of a highly lipophilic compound in dogs. AAPS PharmSci. 3 (2001) E8
    • (2001) AAPS PharmSci. , vol.3
    • De Jaeghere, F.1    Allemann, E.2    Doelker, E.3    Gurry, R.4
  • 4
    • 33846637355 scopus 로고    scopus 로고
    • Dong, W., 2005. Multiparticulate drug delivery system for lipophilic drugs and macromolecule drugs. Ph.D. Thesis. Freie Universität Berlin. www.diss.fu-berlin.de/2005/281.
  • 5
    • 33750451927 scopus 로고    scopus 로고
    • Encapsulation of lipophilic drugs within enteric microparticles by a novel coacervation method
    • Dong W., and Bodmeier R. Encapsulation of lipophilic drugs within enteric microparticles by a novel coacervation method. Int. J. Pharm. 326 (2006) 128-138
    • (2006) Int. J. Pharm. , vol.326 , pp. 128-138
    • Dong, W.1    Bodmeier, R.2
  • 6
    • 0032526833 scopus 로고    scopus 로고
    • Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation
    • El-Zein H., Riad L., and El-Bary A.A. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int. J. Pharm. 168 (1998) 209-220
    • (1998) Int. J. Pharm. , vol.168 , pp. 209-220
    • El-Zein, H.1    Riad, L.2    El-Bary, A.A.3
  • 7
    • 0022402243 scopus 로고
    • Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents
    • Hasegawa A., Kawamura R., Nakagawa H., and Sugimoto I. Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents. Chem. Pharm. Bull. 33 (1985) 3429-3435
    • (1985) Chem. Pharm. Bull. , vol.33 , pp. 3429-3435
    • Hasegawa, A.1    Kawamura, R.2    Nakagawa, H.3    Sugimoto, I.4
  • 9
    • 33846637354 scopus 로고
    • Decreased dissolution of phenylbutazone-PEG 6000 solid dispersions upon storage
    • Khalil S.A.H., and Mortada L.M. Decreased dissolution of phenylbutazone-PEG 6000 solid dispersions upon storage. J. Drug Res. 10 (1978) 141-150
    • (1978) J. Drug Res. , vol.10 , pp. 141-150
    • Khalil, S.A.H.1    Mortada, L.M.2
  • 10
    • 0025983005 scopus 로고
    • Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates
    • Kislalioglu M.S., Khan M.A., Blount C., Goettsch R.W., and Bolton S. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates. J. Pharm. Sci. 80 (1991) 799-804
    • (1991) J. Pharm. Sci. , vol.80 , pp. 799-804
    • Kislalioglu, M.S.1    Khan, M.A.2    Blount, C.3    Goettsch, R.W.4    Bolton, S.5
  • 11
    • 0032857922 scopus 로고    scopus 로고
    • Development of oral drug delivery system using floating microspheres
    • Lee J.H., Park T.G., and Choi H.K. Development of oral drug delivery system using floating microspheres. J. Microencapsul. 16 (1999) 715-729
    • (1999) J. Microencapsul. , vol.16 , pp. 715-729
    • Lee, J.H.1    Park, T.G.2    Choi, H.K.3
  • 12
    • 0028850112 scopus 로고
    • Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice
    • Leroux J.C., Cozens R., Roesel J.L., Galli B., Kubel F., Doelker E., and Gurny R. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J. Pharm. Sci. 84 (1995) 1387-1391
    • (1995) J. Pharm. Sci. , vol.84 , pp. 1387-1391
    • Leroux, J.C.1    Cozens, R.2    Roesel, J.L.3    Galli, B.4    Kubel, F.5    Doelker, E.6    Gurny, R.7
  • 13
    • 0029962749 scopus 로고    scopus 로고
    • pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs
    • Leroux J.C., Cozens R., Roesel J.L., Galli B., Doelker E., and Gurny R. pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs. Pharm. Res. 13 (1996) 485-487
    • (1996) Pharm. Res. , vol.13 , pp. 485-487
    • Leroux, J.C.1    Cozens, R.2    Roesel, J.L.3    Galli, B.4    Doelker, E.5    Gurny, R.6
  • 14
    • 0025893083 scopus 로고
    • Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin
    • Morishita I., Morishita M., Machida Y., and Nagai T. Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin. Drug Des. Deliv. 7 (1991) 309-319
    • (1991) Drug Des. Deliv. , vol.7 , pp. 309-319
    • Morishita, I.1    Morishita, M.2    Machida, Y.3    Nagai, T.4
  • 15
    • 0037173535 scopus 로고    scopus 로고
    • Decreased bioavailability of carbamazepine suppository after its intrarectal and intracolostomal administration to rectal-resected or colostoma-constructed rabbits
    • Nagasawa K., Nakanishi H., Yamamoto R., Kintsuji S., and Fujimoto S. Decreased bioavailability of carbamazepine suppository after its intrarectal and intracolostomal administration to rectal-resected or colostoma-constructed rabbits. Int. J. Pharm. 241 (2002) 375-384
    • (2002) Int. J. Pharm. , vol.241 , pp. 375-384
    • Nagasawa, K.1    Nakanishi, H.2    Yamamoto, R.3    Kintsuji, S.4    Fujimoto, S.5
  • 17
    • 0032885450 scopus 로고    scopus 로고
    • Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs
    • Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88 (1999) 1058-1066
    • (1999) J. Pharm. Sci. , vol.88 , pp. 1058-1066
    • Serajuddin, A.T.M.1
  • 18
    • 0036771080 scopus 로고    scopus 로고
    • Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method
    • Sethia S., and Squillante E. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. J. Pharm. Sci. 91 (2002) 1948-1957
    • (2002) J. Pharm. Sci. , vol.91 , pp. 1948-1957
    • Sethia, S.1    Squillante, E.2
  • 19
    • 0024544487 scopus 로고
    • Enteric solid dispersion of ciyclosporin A (CiA) having potential to deliver CiA into lymphatics
    • Takada K., Oh-hashi M., Furuya Y., Yoshikawa H., and Muranishi S. Enteric solid dispersion of ciyclosporin A (CiA) having potential to deliver CiA into lymphatics. Chem. Pharm. Bull. 37 (1989) 471-474
    • (1989) Chem. Pharm. Bull. , vol.37 , pp. 471-474
    • Takada, K.1    Oh-hashi, M.2    Furuya, Y.3    Yoshikawa, H.4    Muranishi, S.5
  • 22
    • 0035045372 scopus 로고    scopus 로고
    • Naproxen-Eudragit microspheres: screening of process and formulation variable for the preparation of extended release tablets
    • Zaghloul A.A., Faltinek J., Vaithiyalingam S.R., Reddy I.K., and Khan M.A. Naproxen-Eudragit microspheres: screening of process and formulation variable for the preparation of extended release tablets. Pharmazie 56 (2001) 321-324
    • (2001) Pharmazie , vol.56 , pp. 321-324
    • Zaghloul, A.A.1    Faltinek, J.2    Vaithiyalingam, S.R.3    Reddy, I.K.4    Khan, M.A.5
  • 23
    • 0035217531 scopus 로고    scopus 로고
    • Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55
    • Zaghloul A.A., Vaithiyalingam S.R., Faltinek J., Reddy I.K., and Khan M.A. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55. J. Microencapsul. 18 (2001) 651-662
    • (2001) J. Microencapsul. , vol.18 , pp. 651-662
    • Zaghloul, A.A.1    Vaithiyalingam, S.R.2    Faltinek, J.3    Reddy, I.K.4    Khan, M.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.